Jennifer K Fredrickson

Title: The Innovations of Jennifer K. Fredrickson

Introduction

Jennifer K. Fredrickson, an accomplished inventor based in Kalamazoo, MI, has made significant contributions to the pharmaceutical industry. With a focus on improving treatments for muscarinic receptor-mediated disorders, she holds a patent that exemplifies her dedication to innovation in healthcare.

Latest Patents

Jennifer is credited with one notable patent: the Oral liquid tolterodine composition. This pharmaceutical composition is designed as an orally deliverable liquid, which contains water and a pharmaceutically acceptable water-soluble salt of a tolterodine-related compound at a therapeutically effective concentration. The composition maintains a pH of about 2 to about 6 and includes a sweetening agent and an antimicrobial agent that is effective at this pH level. It offers a solution for treating overactive bladder in subjects, demonstrating her commitment to enhancing patient care.

Career Highlights

Jennifer K. Fredrickson is employed at Pharmacia & Upjohn Company, a well-regarded entity in pharmaceuticals. Her role enables her to contribute to essential research and development initiatives aimed at pioneering innovative healthcare solutions.

Collaborations

Throughout her career, Jennifer has worked alongside noteworthy colleagues, including Joseph Peter Reo and Kathryn M. Kienle. These collaborations reflect the dynamic environment in which she operates, fostering creativity and development within her field.

Conclusion

Jennifer K. Fredrickson represents a remarkable example of how dedication and innovation can lead to advancements in medical treatments. Her patent and ongoing work at Pharmacia & Upjohn Company highlight her significant impact on the pharmaceutical landscape, promising better health outcomes for patients with muscarinic receptor-mediated disorders.